Literature DB >> 1036670

Prolonged rupture of membranes, pre-eclamptic toxaemia, and respiratory distress syndrome.

M L Chiswick.   

Abstract

A retrospective analysis was made of the incidence and severity of the idiopathic respiratory distress syndrome (RDS) in babies of less than 35 weeks' gestation born at this hospital from January 1967-December 1974. There was a lower incidence of RDS in babies born after pregnancies complicated only by prolonged rupture of membranes (PRM) (19%) and in babies born vaginally after pregnancies complicated only by pre-eclamptic toxaemia (PET) (18%) compared with the incidence of RDS after uncomplicated pregnancies (35%). Babies born vaginally who developed RDS after pregnancies complicated by PRM or PET had less severe disease compared with those who developed RDS after uncomplicated pregnancies. Mortality in babies who developed severe RDS was not influenced by the occurrence of PRM or PET. The biological implication of the study is that certain complications of pregnancy may accelerate pulmonary surfactant production in preterm babies.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1036670      PMCID: PMC1546259          DOI: 10.1136/adc.51.9.674

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


  27 in total

1.  Observations on the relationship between duration of rupture of the membranes and the development of idiopathic respiratory distress syndrome.

Authors:  J J Yoon; R G Harper
Journal:  Pediatrics       Date:  1973-08       Impact factor: 7.124

2.  Accelerated pulmonary surfactant after untrauterine infection in the fetal rabbit.

Authors:  R V Kotas
Journal:  Pediatrics       Date:  1973-04       Impact factor: 7.124

3.  Maternal and fetal levels of HCS in preeclampsia.

Authors:  A D Sprague; J L Duhring; R J Moser; D Hollingsworth
Journal:  Obstet Gynecol       Date:  1973-05       Impact factor: 7.661

4.  The effect of thyroxine on the maturation of fetal rabbit lungs.

Authors:  B Wu; Y Kikkawa; M M Orzalesi; E K Motoyama; M Kaibara; C J Zigas; C D Cook
Journal:  Biol Neonate       Date:  1973

5.  Prolonged rupture of membranes associated with a decreased incidence of respiratory distress syndrome.

Authors:  C R Bauer; L Stern; E Colle
Journal:  Pediatrics       Date:  1974-01       Impact factor: 7.124

6.  Response of fetal adrenal cortex to congenital infections.

Authors:  B I Osburn; M Drost; G H Stabenfeldt
Journal:  Am J Obstet Gynecol       Date:  1972-11-01       Impact factor: 8.661

7.  The role of the pituitary-adrenal-thyroid axes in lung differentiation. I. Studies of the cytology and physical properties of anencephalic fetal rat lung.

Authors:  W R Blackburn; H Travers; D M Potter
Journal:  Lab Invest       Date:  1972-03       Impact factor: 5.662

8.  Thyroid hormone influence upon lung surfactant metabolism.

Authors:  R A Redding; W H Douglas; M Stein
Journal:  Science       Date:  1972-03-03       Impact factor: 47.728

9.  Adrenal gland structure and the development of hyaline membrane disease.

Authors:  R L Naeye; H T Harcke; W A Blanc
Journal:  Pediatrics       Date:  1971-04       Impact factor: 7.124

10.  Biochemical development of surface activity in mammalian lung. IV. Pulmonary lecithin synthesis in the human fetus and newborn and etiology of the respiratory distress syndrome.

Authors:  L Gluck; M V Kulovich; A I Eidelman; L Cordero; A F Khazin
Journal:  Pediatr Res       Date:  1972-02       Impact factor: 3.756

View more
  10 in total

1.  Colfosceril palmitate. A pharmacoeconomic evaluation of a synthetic surfactant preparation (Exosurf Neonatal) in infants with respiratory distress syndrome.

Authors:  H M Bryson; R Whittington
Journal:  Pharmacoeconomics       Date:  1994-12       Impact factor: 4.981

2.  Factors influencing surfactant composition in the newborn infant.

Authors:  M Obladen
Journal:  Eur J Pediatr       Date:  1978-07-03       Impact factor: 3.183

3.  Gestational age assessment by the lens examination method in normal and pathological pregnancies.

Authors:  E Z Zimmer; P Sujov; I Tchernin; B A Peretz
Journal:  Eur J Pediatr       Date:  1983-10       Impact factor: 3.183

4.  Outcomes of small for gestational age infants born at <27 weeks' gestation.

Authors:  Lilia C De Jesus; Athina Pappas; Seetha Shankaran; Lei Li; Abhik Das; Edward F Bell; Barbara J Stoll; Abbot R Laptook; Michele C Walsh; Ellen C Hale; Nancy S Newman; Rebecca Bara; Rosemary D Higgins
Journal:  J Pediatr       Date:  2013-02-14       Impact factor: 4.406

5.  Stress response and its relationship to cystic (pseudofollicular) change in the definitive cortex of the adrenal gland in stillborn infants.

Authors:  D J de Sa
Journal:  Arch Dis Child       Date:  1978-10       Impact factor: 3.791

6.  Severe pre-eclampsia and infants of very low birth weight.

Authors:  W Szymonowicz; V Y Yu
Journal:  Arch Dis Child       Date:  1987-07       Impact factor: 3.791

7.  Increased incidence of respiratory distress syndrome in babies of hypertensive mothers.

Authors:  T R Tubman; M D Rollins; C Patterson; H L Halliday
Journal:  Arch Dis Child       Date:  1991-01       Impact factor: 3.791

8.  Circulating anti-angiogenic factors during hypertensive pregnancy and increased risk of respiratory distress syndrome in preterm neonates.

Authors:  Alice Wang; Alexander M Holston; Kai F Yu; Jun Zhang; Mourad Toporsian; S Ananth Karumanchi; Richard J Levine
Journal:  J Matern Fetal Neonatal Med       Date:  2011-12-13

9.  Preeclampsia and the risk of bronchopulmonary dysplasia in VLBW infants: a population based study.

Authors:  Ting-An Yen; Hwai-I Yang; Wu-Shiun Hsieh; Hung-Chieh Chou; Chien-Yi Chen; Kuo-Inn Tsou; Po-Nien Tsao
Journal:  PLoS One       Date:  2013-09-20       Impact factor: 3.240

10.  Effect of early postnatal neutropenia in very low birth weight infants born to mothers with pregnancy-induced hypertension.

Authors:  Yang Hee Park; Gyung Min Lee; Jung Min Yoon; Enn Jung Cheon; Kyung Ok Ko; Yung Hyuk Lee; Jae Woo Lim
Journal:  Korean J Pediatr       Date:  2012-12-20
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.